Article
Exploration of Practical Biomarkers for Systemic Drug Therapy for Hepatocellular Carcinoma
2023-07-17
Abstract excerpt
A number of agents, including immune checkpoint inhibitors, have become available for the treatment of hepatocellular carcinoma (HCC). However, the objective response rate of these drugs is currently only 30% to 40%, with a high incidence of side effects. There are also no prac-tical biomarkers to predict their therapeutic effects. Most of the systemic therapies for HCC are performed in general hospitals without r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3fdd3cf9-f7b8-5b1d-8d18-e87b1a3af341
- DOI
- 10.20944/preprints202307.0539.v3